Nuvaira Stock

nuvaira.comHealthcareFounded: 2008Funding to Date: $150.32MM

Nuvaira is a medical device company that develops therapies to improve outcomes for patients suffering from obstructive lung diseases by addressing underlying disease pathophysiology.

Register for Details

For more details on financing and valuation for Nuvaira, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Dennis Wahr MD
President, Chief Executive Officer and Board Member
Kari Golembeck Kubesh
Chief Financial Officer
Martin Mayse MD
Chief Technology Officer & Co-Founder
Lorraine Marshall Wright
Senior Marketing Consultant
Shane Gleason
Chief Commercial Officer
Joseph Ostendorg
Regulatory Affairs & Quality Systems Manager
Jim Pavliska
Vice President of Clinical Affairs
Mahtab Fatemi JD
Vice President, Regulatory Affairs & Quality

Board Members

Alexander Schmitz
Endeavour Vision
Carolyn Ng Ph.D
Vertex Ventures HC
Christopher Shen MD
Qiming Venture Partners
David Stassen
Split Rock Partners
Henry Plain Jr.
Morgenthaler Ventures
James Lee Tze Wei
Jonathan Root MD
US Venture Partners
Kirk Nielsen
Versant Venture Management
Mark Deem
Lightstone Ventures
Michael Carusi
Advanced Technology Ventures

Other companies like Nuvaira in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$263MM

News

Minneapolis, Minnesota-based Nuvaira has raised $79 million in funding to further develop its novel therapeutic medical devices for treating obstructive lung diseases.